Published in Yale J Biol Med on November 25, 1977
Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet (1974) 8.13
Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med (1974) 6.77
Microangiopathic haemolytic anaemia: the possible role of vascular lesions in pathogenesis. Br J Haematol (1962) 6.08
PLASMA CELL MYELOMA: GAMMA GLOBULIN SYNTHESIS AND STRUCTURE. A REVIEW OF BIOCHEMICAL AND CLINICAL DATA, WITH THE DESCRIPTION OF A NEWLY-RECOGNIZED AND RELATED SYNDROME, "H-GAMMA-2-CHAIN (FRANKLIN'S) DISEASE. Medicine (Baltimore) (1963) 3.46
Platelet and fibrinogen consumption in man. N Engl J Med (1972) 2.20
Failed Splenectomy in Acholuric Jaundice. Br Med J (1938) 2.19
The anemia of cancer patients and its relation to metastases to the bone marrow. J Lab Clin Med (1951) 1.45
Thirty cases of monoclonal immunoglobulin disorders other than myeloma or macroglobulinemia. A classification of diseases associated with the production of monoclonal-type immunoglobulins. Am J Med (1969) 1.38
The pathogenesis of anemia in patients with carcinoma. Am J Med (1955) 1.37
Autoimmune hemolytic anemia. Arch Intern Med (1975) 1.37
Symptomatic haemolytic anaemia associated with ovarian teratoma in child. J Clin Pathol (1951) 1.27
Studies on the anemia of disseminated malignant neoplastic disease. II. Study of the life span of the erythrocyte. Blood (1956) 1.23
Autoimmune haemolytic anaemia and ovarian tumour. Br J Haematol (1971) 1.22
Plasmacytosis and cryoglobulinemia in cancer. J Am Med Assoc (1957) 1.20
The nature of cancer anaemia and its bearing on the immunological theory of cancer. Br Med J (1957) 1.14
Auto-immune hemolytic anemia arrested by removal of an ovarian teratoma: review of the literature and report of a case. Ann Intern Med (1957) 1.11
Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma. Br J Haematol (1970) 1.04
Autoimmune hemolytic anemia and neoplasia of the reticuloendothelium. With a hypothesis concerning etiologic relationships. Ann Intern Med (1968) 0.95
Monoclonal gammopathy in lymphoma. Arch Intern Med (1975) 0.93
AUTOIMMUNE HEMOLYTIC ANEMIA AND CANCER. JAMA (1965) 0.92
Microangiopathic hemolytic anemia in metastatic carcinoma. Report of eight cases. Ann Intern Med (1973) 0.90
Hematologic manifestations of metastatic gastric malignancy. Gastroenterology (1954) 0.89
Hematologic manifestations of malignant disease. Med Clin North Am (1963) 0.86
Monoclonal gammopathy in human neoplasia. Cancer (1968) 0.85
Hemolytic anemia, a host response to malignancy. Cancer Res (1957) 0.85
Serologic profile in autoimmune hemolytic disease: pathophysiologic and clinical interpretations. Semin Hematol (1976) 0.84
HAEMOLYTIC ANAEMIA ASSOCIATED WITH OVARIAN TERATOMA. Br Med J (1964) 0.84
Ovarian neoplasm associated with autoimmune hemolytic anemia. Am J Obstet Gynecol (1966) 0.83
Autoimmune haemolytic anaemia associated with ovarian dermoid cyst. J Clin Pathol (1968) 0.82
Current knowledge and concepts of the relationship of malignancy, autoimmunity, and immunologic disease. Ann N Y Acad Sci (1974) 0.81
Autoimmune hemolytic anemia associated with colon cancer. Cancer (1974) 0.80
[Autoimmune hemolytic anemia and malignant tumor of the ovary]. Presse Med (1969) 0.80
Ovarian malignancy and hemolytic anemia. Demonstration of a hemolytic serum factor. Ann Intern Med (1970) 0.80
The direct Coombs' test: its clinical significance. Study in a large university hospital. Ann Intern Med (1968) 0.80
Positive antiglobulin reactions complicating urological surgery. J Urol (1966) 0.77
Hemolytic anemia associated with an ovarian tumor. Am J Med (1971) 0.77
Field evaluation of Thayer-Martin medium for identification of meningococcus carriers. Am J Epidemiol (1965) 4.06
Immunofluorescence techniques for demonstrating bacterial pathogens associated with cerebrospinal meningitis. 3. Identification of meningococci from the nasopharynx of asymptomatic carriers. Am J Epidemiol (1966) 3.72
Evidence for a precursor to circulating parathyroid hormone. Proc Natl Acad Sci U S A (1970) 1.81
Activation of suppressor T cells by tumour cells and specific antibody. Nature (1974) 1.67
On the mode of action of BCG. Nat New Biol (1973) 1.47
Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci (1989) 1.44
A general journal in a specialized world. Yale J Biol Med (1976) 1.39
Activation of lymphoid cells by BCG in vitro. Cell Immunol (1975) 1.38
Atypical decubital fibroplasia. A distinctive fibroblastic pseudotumor occurring in debilitated patients. Am J Surg Pathol (1992) 1.25
Pulmonary manifestations in Behçet syndrome. Case report and review of the literature. Arch Intern Med (1976) 1.23
The N-terminal ATPase site in the large terminase protein gp17 is critically required for DNA packaging in bacteriophage T4. J Mol Biol (2001) 1.20
Synthesis and secretion of parathyroid hormone in vitro. Am J Med (1971) 1.17
Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann Intern Med (1969) 1.14
Antigen-antibody complexes generate Lyt 1 inducers of suppressor cells. J Immunol (1980) 1.11
Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells. Proc Natl Acad Sci U S A (1978) 1.06
Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide. Int J Cancer (1998) 1.01
Improved therapeutic index of methotrexate with "leucovorin rescue". Cancer Res (1973) 0.99
Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res (1984) 0.99
Renal failure secondary to leukemic infiltration of the kidneys. Am J Med (1977) 0.98
Immunosuppressive therapy for the eye changes of Graves' disease. J Clin Endocrinol Metab (1970) 0.97
Studies on the immunogical effects of BCG and its components: theoritical and therapeutic implications. Biomedicine (1976) 0.95
Human placental lactogen (HPL) and placental weight. Am J Obstet Gynecol (1968) 0.95
Immunological responses to L-asparaginase. J Clin Invest (1971) 0.94
Case report: clinical findings and successful resection of melanoma metastatic to the right atrium. Cancer Invest (1994) 0.94
Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck. Cancer Res (1968) 0.93
Structural evidence for distinct IgG subclass-specific Fc receptors on mouse peritoneal macrophages. J Exp Med (1980) 0.92
Effects of chemotherapeutic agents on the immune response. I. Cancer Invest (1984) 0.90
Suppressor T cells induced by soluble immune complexes can adoptively transfer inhibition of cytophilic antibody receptors on macrophages. Cell Immunol (1979) 0.90
The production of tolerance to human erythrocytes in the rat with cytosine arabinoside or cyclophosphamide. J Immunol (1969) 0.90
Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients. Cancer Immunol Immunother (1991) 0.90
Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation. Blood (1986) 0.89
Human monoclonal antibodies directed against melanoma tumor-associated antigens. Cancer Res (1986) 0.88
Leptomeningeal mycosis fungoides. Cancer (1976) 0.88
Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART-1. Eur J Immunol (2000) 0.88
Effect of imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazeno) on immunity in patients with malignant melanoma. Cancer Res (1974) 0.87
Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma. Cancer Immunol Immunother (1993) 0.86
Immunosuppression by 5-fluorouracil. Cancer (1970) 0.86
Hemolytic anemia with positive direct antiglobulin test secondary to spontaneous cytomegalovirus infection in healthy adults. Acta Haematol (1994) 0.85
Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial. Cancer Res (1986) 0.84
Specific in vivo inhibition of macrophage receptors for cytophilic antibody by soluble immune complexes. Cancer Res (1979) 0.84
Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin. Cancer (1978) 0.84
The effect of bioburden on in-depth disinfection of denture base acrylic resin. J Calif Dent Assoc (1998) 0.84
Hemolytic transfusion reaction due to anti-A. Transfusion (1975) 0.83
Immunological aspects of intrinsic glial tumors. J Neurosurg (1981) 0.83
Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice. Cancer Res (1976) 0.83
Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro. Cancer Res (1990) 0.83
Modulation of the immune response by BCG: a review. Yale J Biol Med (1976) 0.82
Immunological effects of recombinant interferon-alpha 2 in cancer patients. J Biol Response Mod (1983) 0.82
Cytophilic antibodies in man. Ann Intern Med (1973) 0.82
Cancer vaccines: novel approaches and new promise. Pharmacol Ther (1999) 0.82
Cell-mediated immunity and blocking factor in ovarian carcinoma. Obstet Gynecol (1976) 0.82
Fatigue in patients with cancer receiving interferon alpha. Cancer Pract (1995) 0.81
Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration. J Clin Oncol (1987) 0.81
Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients. Cancer Immunol Immunother (1994) 0.81
Role of "suppressor" T lymphocytes in antibody-induced inhibition of cytophilic antibody receptors. Ann N Y Acad Sci (1976) 0.81
Effects of chemotherapeutic agents on the immune response. II. Cancer Invest (1985) 0.81
Ventricular arrhythmias associated with the ingestion of alcohol. Ann Intern Med (1972) 0.80
Development of a combination chemotherapy program for adult acute leukemia: CAM and CAM-L. Cancer (1973) 0.80
Modulation of immunity by bacillus Calmette-Guérin (BCG). Pharmacol Ther (1979) 0.80
Lung carcinoma after radiotherapy and chemotherapy for Hodgkin's disease. Thorax (1977) 0.80
The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921). Am J Clin Oncol (1996) 0.80
Failure of bleomycin to affect humoral or cell-mediated immunity in the mouse. Cancer Res (1974) 0.79
Effects of vancomycin on platelets, plasma proteins and hepatitis B surface antigen. Thromb Diath Haemorrh (1975) 0.79
Immunotherapy with bacterial endotoxins. Adv Exp Med Biol (1990) 0.79
A laboratory model for the study of the immunobiology of osteosarcoma. Cancer (1975) 0.79
Combination sequential chemotherapy in advanced reticulum cell sarcoma. Cancer (1972) 0.79
Systemic methotrexate toxicity. A pharmacological study of its occurrence after intrathecal administration in a patient with renal failure. Arch Intern Med (1976) 0.79
Novel gene sequences expressed by human melanoma cells identified by molecular subtraction. Cancer Res (1991) 0.79
Selectivity in the effects of indomethacin on BCG-activated suppressor cell populations. J Immunopharmacol (1981) 0.79
Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy. Cancer Immunol Immunother (1993) 0.78
Assignment of a human melanoma associated gene MG50 (D2S448) to chromosome 2p25.3 by fluorescence in situ hybridization. Genomics (1994) 0.78
Studies on the relationship of human natural killer and lymphokine-activated killer cells with lysosomal staining and analysis of surface marker phenotypes. Cell Immunol (1988) 0.78
Active specific immunotherapy of metastatic melanoma with an antiidiotype vaccine: a phase I/II trial of I-Mel-2 plus SAF-m. J Clin Oncol (1997) 0.78
Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma. Cancer Treat Rep (1985) 0.77
Alteration of antibody synthesis in the rat by cytosine arabinoside. Cancer Res (1969) 0.77
Specific inhibition of receptors for cytophilic antibody on macrophages by isoantibody. Cancer Res (1972) 0.77
Cytotoxic activity of human pulmonary alveolar macrophages. Cancer Res (1985) 0.77
Spontaneous acute leukemia in polycythemia vera. Ann Intern Med (1976) 0.77
A virally induced osteosarcoma in rats. A model for immunological studies of human osteosarcoma. J Bone Joint Surg Am (1976) 0.77
Analysis and reversal of the inhibition of cytophilic antibody receptors produced by antibody. Cancer Res (1975) 0.77
Therapeutic vaccines for melanoma: progress and problems. Trends Biotechnol (1996) 0.77
Protection against experimental cerebral metastases of murine melanoma B16 by active immunization. Cancer Res (1993) 0.77
Central inhibition of cellular immunity to leukemia L1210 by isoantibody. Cancer Res (1972) 0.77
The management of depression. Part 2. The place of the new antidepressants. Aust Fam Physician (1994) 0.77
Induction of suppressor cells by intravenous administration of Bacillus Calmette-Guérin and its modulation by cyclophosphamide. Biochem Pharmacol (1979) 0.76
Optimization of intracerebral tumour protection by active-specific immunization against murine melanoma B16/G3.12. Melanoma Res (2001) 0.75
Pulmonary granulomas in a patient on MER therapy. Yale J Biol Med (1978) 0.75
Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities. Surgery (1982) 0.75
Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma. J Clin Invest (1977) 0.75
T-cell-mediated immunity to carcinoembryonic antigen in humans: an example of "swimming upstream"? J Natl Cancer Inst (1995) 0.75
Low-dose cyclophosphamide and low-dose interleukin-2 for malignant melanoma. Bull N Y Acad Med (1989) 0.75
High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma. Cancer Treat Rep (1987) 0.75
Modification of response to histocompatibility antigens with chemotherapeutic agents. Transplantation (1971) 0.75
The Yale combination chemotherapy program for advanced Hodgkin's disease. A preliminary report. Conn Med (1970) 0.75
Chemical suppression of primary and anamnestic maternal immunization of Rh-incompatible pregnancies. An animal model. Am J Obstet Gynecol (1970) 0.75
Simplified estimation of mouse isohemagglutinins by microassay. Transplantation (1969) 0.75
Evaluation of bacterial contamination in blood processing. Transfusion (1975) 0.75
The pharmacology of immunosuppressive agents. Conn Med (1970) 0.75
Letter: Positive antiglobulin test after BCG immunotherapy. N Engl J Med (1974) 0.75